Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKRONASDAQ:HEESNYSE:OKLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKROAkero Therapeutics$45.61+6.0%$41.80$17.86▼$58.40$3.63B-0.18874,059 shs1.48 million shsHEESH&E Equipment Services$89.81+0.2%$93.25$40.93▼$101.28$3.29B1.74539,005 shs558,179 shsOKLOOklo$23.79-2.7%$25.37$5.35▼$59.14$3.31B-0.0111.59 million shs6.61 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKROAkero Therapeutics+2.06%+11.79%+0.75%-20.30%+119.37%HEESH&E Equipment Services-0.84%+0.36%-6.09%+1.53%+51.33%OKLOOklo-0.29%+13.47%+8.99%-30.84%+113.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKROAkero Therapeutics3.7887 of 5 stars3.51.00.04.73.41.70.0HEESH&E Equipment Services4.2407 of 5 stars1.25.02.53.53.22.51.9OKLOOklo3.5899 of 5 stars4.32.00.00.02.05.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKROAkero Therapeutics 3.00Buy$76.2967.26% UpsideHEESH&E Equipment Services 2.40Hold$71.33-20.57% DownsideOKLOOklo 2.57Moderate Buy$46.4095.04% UpsideCurrent Analyst Ratings BreakdownLatest AKRO, HEES, and OKLO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/23/2025OKLOOkloHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$55.004/11/2025OKLOOkloBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral3/25/2025OKLOOkloCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$31.00 ➝ $30.003/25/2025OKLOOkloWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$45.00 ➝ $45.003/3/2025AKROAkero TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$72.00 ➝ $75.003/2/2025AKROAkero TherapeuticsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight2/6/2025OKLOOkloB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $58.001/31/2025AKROAkero TherapeuticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$42.00 ➝ $109.001/30/2025AKROAkero TherapeuticsBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$35.00 ➝ $63.00(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKROAkero TherapeuticsN/AN/AN/AN/A$9.61 per shareN/AHEESH&E Equipment Services$1.52B2.17$14.01 per share6.41$14.66 per share6.13OKLOOkloN/AN/A$0.22 per share110.00($0.27) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKROAkero Therapeutics-$151.76M-$3.75N/AN/AN/AN/A-32.46%-29.83%5/9/2025 (Estimated)HEESH&E Equipment Services$169.29M$3.3722.7923.33N/A9.47%25.46%5.16%N/AOKLOOklo$11.87M-$10.13N/AN/AN/AN/A-32.11%-13.72%5/12/2025 (Estimated)Latest AKRO, HEES, and OKLO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025OKLOOklo-$0.10N/AN/AN/AN/AN/A5/9/2025Q1 2025AKROAkero Therapeutics-$1.00N/AN/AN/AN/AN/A4/29/2025Q1 2025HEESH&E Equipment Services$0.66$0.03-$0.63-$0.17$362.60 million$319.46 million3/24/2025Q4 2024OKLOOklo-$0.08-$0.09-$0.01-$0.09N/AN/A2/28/2025Q4 2024AKROAkero Therapeutics-$0.98-$0.99-$0.01-$0.99N/AN/A2/21/2025Q4 2024HEESH&E Equipment Services$0.81$0.99+$0.18$0.90$372.50 million$384.08 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKROAkero TherapeuticsN/AN/AN/AN/AN/AHEESH&E Equipment Services$1.101.22%N/A32.64%N/AOKLOOkloN/AN/AN/AN/AN/ALatest AKRO, HEES, and OKLO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/7/2025HEESH&E Equipment Servicesquarterly$0.27501.26%2/18/20252/18/20252/24/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKROAkero Therapeutics0.0517.2517.25HEESH&E Equipment Services2.090.640.59OKLOOkloN/A48.4548.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKROAkero TherapeuticsN/AHEESH&E Equipment Services84.08%OKLOOklo85.03%Insider OwnershipCompanyInsider OwnershipAKROAkero Therapeutics7.94%HEESH&E Equipment Services12.50%OKLOOklo21.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKROAkero Therapeutics3079.62 million64.26 millionOptionableHEESH&E Equipment Services2,38036.67 million32.03 millionOptionableOKLOOklo78139.19 million95.48 millionOptionableAKRO, HEES, and OKLO HeadlinesRecent News About These CompaniesWhy Oklo Could Lead The Nuclear Power RevolutionMay 1 at 12:01 AM | seekingalpha.comOklo (NYSE:OKLO) Trading Up 0.2% - Should You Buy?April 30 at 2:38 PM | marketbeat.comOklo (NYSE:OKLO) Stock Price Down 1.4% - Here's WhyApril 30 at 2:26 PM | marketbeat.comMGO One Seven LLC Purchases Shares of 12,333 Oklo Inc. (NYSE:OKLO)April 30 at 4:37 AM | marketbeat.comMarshall Wace LLP Makes New $1.25 Million Investment in Oklo Inc. (NYSE:OKLO)April 30 at 3:52 AM | marketbeat.comMariner LLC Cuts Position in Oklo Inc. (NYSE:OKLO)April 30 at 3:44 AM | marketbeat.comOklo Inc.April 29 at 11:49 PM | wsj.comLegal & General Group Plc Has $629,000 Position in Oklo Inc. (NYSE:OKLO)April 29 at 3:40 AM | marketbeat.comHead-To-Head Survey: Oklo (OKLO) & The CompetitionApril 28 at 2:09 AM | americanbankingnews.comWhat is HC Wainwright's Estimate for Oklo Q1 Earnings?April 27 at 1:25 AM | americanbankingnews.comOklo (NYSE:OKLO) Stock Price Down 1.6% - Should You Sell?April 26, 2025 | marketbeat.comHC Wainwright Estimates Oklo's Q1 Earnings (NYSE:OKLO)April 26, 2025 | marketbeat.comOklo (NYSE:OKLO) Now Covered by Analysts at HC WainwrightApril 26, 2025 | americanbankingnews.comCritical Comparison: Oklo (OKLO) & Its RivalsApril 26, 2025 | americanbankingnews.comOklo (NYSE:OKLO) Stock Price Up 6.2% - Here's What HappenedApril 25, 2025 | marketbeat.comHead-To-Head Review: Oklo (NYSE:OKLO) versus OGE Energy (NYSE:OGE)April 25, 2025 | americanbankingnews.comTwo Market Bottom Signals With Perfect Track RecordsApril 24, 2025 | zacks.comOverlooked Stock: OKLOApril 24, 2025 | youtube.comSam Altman steps down from Oklo board amid potential OpenAI energy partnerships: ReportsApril 24, 2025 | msn.comOklo (NYSE:OKLO) Stock Price Up 9.6% - Should You Buy?April 24, 2025 | marketbeat.comOklo (NYSE:OKLO) Coverage Initiated by Analysts at HC WainwrightApril 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAKRO, HEES, and OKLO Company DescriptionsAkero Therapeutics NASDAQ:AKRO$45.61 +2.57 (+5.97%) As of 04:00 PM EasternAkero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.H&E Equipment Services NASDAQ:HEES$89.81 +0.19 (+0.21%) As of 04:00 PM EasternH&E Equipment Services, Inc. engages in the provision of equipment services, which focus on heavy construction and industrial equipment. It operates through the following segments: Equipment Rentals, New Equipment Sales, Used Equipment Sales, Parts Sales, and Services. The Equipment Rentals segment focuses on renting construction and industrial equipment. The New Equipment Sales segment is involved in selling new equipment in product categories. The Used Equipment Sales segment offers rental fleet and inventoried equipment that are acquired through trade-ins and through purchases of high quality used equipment. The Parts Sales segment includes new and used parts for the equipment and rental fleet. The Services segment operation provides maintenance and repair services for customers’ equipment and to rental fleet. The company was founded by Tom Engquist and Frank Head in 1961 and is headquartered in Baton Rouge, LA.Oklo NYSE:OKLO$23.79 -0.65 (-2.66%) As of 03:59 PM EasternOklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
